OSIRIS THERAPEUTICS, INC.·4

Feb 7, 9:33 AM ET

OSIRIS THERAPEUTICS, INC. 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 7, 2014

Insider Transaction Report

Form 4
Period: 2014-02-06
FRIEDLI PETER
Director10% OwnerOther
Transactions
  • Award

    Common Stock

    2014-02-06$14.93/sh+10,000$149,30010,204,404 total
Holdings
  • Common Stock

    (indirect: See Note 2)
    4,606,051
Footnotes (2)
  • [F1]Grant of 10,000 shares of common stock of the Registrant as compensation for services as a member of the Board of Directors during the fiscal year ended December 31, 2013, made under the Amended and Restated 2006 Omnibus Plan.
  • [F2]The Reporting Person holds indirect beneficial ownership of 4,103,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately a 21% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his daughter and spouse and disclaims beneficial interest in the shares held by Venturetec, Inc., beyond the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -